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ARTICLE OPEN
Activating primary care COPD patients with multi-morbidity
through tailored self-management support
Sameera Ansari 1✉, Hassan Hosseinzadeh 2, Sarah Dennis3,4,5,6 and Nicholas Zwar1,7
Given the dearth of COPD self-management interventions that specifically acknowledge multi-morbidity in primary care, we aimed
to activate COPD patients through personalised self-management support that recognised the implications of co-morbidities. This
single-group experimental study included patients aged 40−84 with a spirometry diagnosis of COPD and at least one co-morbidity.
A self-management education programme for COPD in the context of multi-morbidity, based on the Health Belief Model, was
tailored and delivered to participants by general practice nurses in face-to-face sessions. At 6 months’ follow-up, there was
significant improvement in patient activation (p < 0.001), COPD-related quality of life (p= 0.012), COPD knowledge (p < 0.001) and
inhaler device technique (p= 0.001), with no significant change in perception of multi-morbidity (p= 0.822) or COPD-related multi-
morbidity (0.084). The programme improved patients’ self-efficacy for their COPD as well as overall health behaviour. The findings
form an empirical basis for further testing the programme in a large-scale randomised controlled trial.
npj Primary Care Respiratory Medicine           (2020) 30:12 ; https://doi.org/10.1038/s41533-020-0171-5
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is currently the third
leading cause of mortality worldwide, with 3 million people having
died of the disease in 20161. COPD often occurs in the presence of
co-morbidities, which might have concordant or discordant
pathophysiology2. In Australia, COPD was the fifth leading cause
of death in 20153, with 91% of those reported to have COPD
experiencing at least one co-morbidity4. Co-morbidities contribute
to poor health status and higher healthcare utilisation5, and
aggravate the debilitating nature of COPD6.
Since the majority of the Australian population visit their
general practitioner (GP) more than once a year7, general practice
offers the continuity of care needed for interventions aimed at
enhancing patients’ self-management of chronic disease. With
practice nurses (PNs) increasingly contributing to chronic disease
management, nurse-delivered self-management support for
coordinated care of patients with COPD could lead to significant
uptake of interventions shown to improve health outcomes such
as smoking cessation, pulmonary rehabilitation and influenza
vaccination8,9. For such interventions to be effective, patients
need to be involved in active discussion that would enhance their
self-efficacy for management of COPD10.
A qualitative study by the authors found that people with early-
stage COPD have difficulty recognising the importance of the
condition and its long-term implications and COPD may be given
low priority compared to their other co-morbidities11. While self-
management interventions for patients with COPD can improve
health-related quality of life and reduce respiratory-related
hospital admissions12, most prior studies have focussed on COPD
alone and only included patients with moderate or severe
disease13–16. A meta-analysis of seven studies of community-
based, self-management interventions among primary care COPD
patients found no between-group difference in health-related
quality of life at final follow-up17. There is evidence that a multi-
faceted approach is needed to bring about change in health
behaviour among those with COPD and providing them with only
disease knowledge is not enough18. Due to the heterogeneous
nature of the disease, effective self-management for COPD needs
personalised education and active guidance19. Given that most
patients with chronic respiratory disease have other chronic
conditions20, it is essential to include strategies for coping with
multi-morbidity in COPD self-management interventions11,21.
To date, no research study has provided a behaviour change
theory-based, tailored, self-management support for COPD in
the context of multi-morbidity, particularly in the primary care
setting. The Activating Primary Care COPD Patients with Multi-
morbidity (APCOM) study aimed to activate patients in regard to
their COPD while acknowledging and tailoring support to
recognise the implications existing of co-morbidities. It was
hypothesised that at 6 months’ follow-up after a tailored, self-
management education programme, participating patients
would have: (i) better activation in terms of their COPD-related
health behaviour, (ii) improved knowledge and self-
management capacity of COPD, and (iii) increased self-efficacy
in terms of their overall health behaviour.
RESULTS
Recruitment
Among 61 practices invited to participate, 13 (21%) consented to
take part, 17 (28%) did not respond and 31 (51%) declined. One
practice withdrew due to lack of potential patients after the PN
conducted a medical record search. A total of 226 patients were
invited to participate in the study (Fig. 1), of whom 50 eventually
participated in the study. Each PN managed between two and
seven patients during the study.
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Patient characteristics
Of 50 patients at baseline, 44 completed 6 months’ follow-up.
Their baseline characteristics are summarised in Table 1. There
were a total 90 co-morbidities among the 50 patients at baseline.
Hypertension (56%), hyperlipidaemia (48%), gastro-oesophageal
reflux disease (40%), ischaemic heart disease (38%), depression
(30%), asthma (28%), diabetes (28%), osteoarthritis (24%),
osteoporosis (24%) and anxiety (22%) were the ten most recurring
co-morbidities.
Change in the study’s outcome measures
As seen in Table 2, there was a significant increase (<0.001) of 7.16
points in the Patient Activation Measure 13 (PAM 13), the primary
outcome measure. There was also a significant increase (<0.001) of
1.75 in the patients’ knowledge of COPD, measured by the COPD
Knowledge Questionnaire (COPD-Q), at 6 months’ follow-up. The
patients’ COPD-related quality of life was also significantly
improved (0.012), with a change of 2.45 points in their COPD
Assessment Test (CAT) score.
The change of 0.44 in patients’ perception of the burden of their
multi-morbidity, measured by the Multimorbidity Illness Percep-
tions Scale (MULTIPleS), was not significant (p= 0.822), nor was
the difference of 1.76 in perception of their COPD in the context of
multi-morbidity (p= 0.084). There was significant improvement in
inhaler device technique (p= 0.001), with 50% more patients
having proper inhaler technique at 6 months’ follow-up.
Table 3 details the change in outcome measures for a subset of
35 patients who attended all three sessions of the programme.
They also had a significant improvement in activation (p < 0.001),
COPD knowledge (p < 0.001), COPD-related quality of life (0.024)
and inhaler device technique (0.002). There was no significant
change in their perception of multi-morbidity (0.907) or COPD-
related multi-morbidity (0.237).
DISCUSSION
Our findings indicated that the self-management education
programme led to significant improvement in patient activation,
COPD knowledge, COPD-related quality of life and inhaler device
technique. These changes supported the three hypotheses
postulated by the study and also support the idea that a theory-
based, tailored self-management programme that recognises and
responds to the presence of existing co-morbidities may be more
effective than current approaches.
There was a statistically significant increase in the patients’ level
of activation in terms of their overall health behaviour, as
measured by the PAM 1322. Even though the mean post-test
score of the PAM remained in Stage 3 at 6 months’ follow-up, the
increase of 7.16 points was meaningful as a minimum increase of
four points following an intervention suggests a clinical improve-
ment in self-efficacy23. This increase in the PAM indicated that, on
an average, the patients were in control of their own health-
related behaviour but needed motivation to adopt and maintain
new behaviours24.
Prior interventional studies for chronic disease have had similar
outcomes in terms of patient activation. A home-based educa-
tional intervention for native Americans with type 2 diabetes by
Shah et al.25 found a significant increase in patient activation.
Another self-management intervention for diabetic patients in
Norwegian primary care demonstrated a persistent increase in
their level of activation26. In their secondary analysis of a
randomised trial of self-care for patients with depression and co-
morbidities, McCusker et al.27 found that activation significantly
improved in both coached and non-coached groups at 6 months’
follow-up. Another self-management intervention for COPD in the
UK by Turner et al.23 demonstrated a significant improvement in
paired measures of patient activation.
There was significantly improved COPD-related quality of life
following the APCOM programme, as assessed by the CAT28. This
is in contrast to a previous general practice-based study29, and to
the findings of the systematic review by Jolly et al.17, which found
no improvement in health-related quality of life as assessed by the
St George’s Respiratory Questionnaire. In a trial of self-
management for COPD by Bischoff et al.30, comprehensive,
Fig. 1 Recruitment of patient participants and uptake of the
programme. It shows the response rate of patient participants and
rate of completion of the APCOM programme.
Table 1. Baseline characteristics of patient participants.
Characteristic N= 50
Sex Male: 25 (50%)
Female: 25 (50%)
Age—Mean years (SD) 69.22 (±8.43)
Ethnicity Caucasian 44 (88%)
Asian 3 (6%)
Arabic 2 (4%)
Other 1 (2%)
Level of education University 16 (32%)
Some high school 15 (30%)
HSC 15 (30%)
TAFE 3 (6%)
Primary school 1 (2%)
Employment status Retired 38 (76%)
Employed 7 (14%)
Unemployed 4 (8%)
Carer 1 (2%)
Living arrangement With someone 35 (70%)
Alone 15 (30%)
BMI (SD) 28.99 (±6.19)
Smoking status Ex-smoker 31 (62%)
Current smoker 12 (24%)
Never smoked 7 (14%)
Prior experience of pulmonary
rehabilitation
Yes 8 (16%)
No 42 (84%)
Outcome measures Mean (SD)
PAM 13 57.68 (±10.83)
COPD-Q 7.24 (±2.12)
CAT 19.22 (±6.95)
MULTIPleS 25.3 (±14.07)
COPD-MULTIPleS 11.76 (±6.64)
Correct inhaler device technique (n= 36) 6 (16.67%)
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tailored PN-delivered education and routine monitoring did not
show better quality of life or self-efficacy. This could be attributed
to the single disease-focussed nature of their intervention. Some
prior self-management interventions for COPD have yielded
positive outcomes. Another PN-led self-management intervention
for patients with COPD in the UK showed a significant
improvement in their CAT scores31, which are in line with our
study’s findings. A pilot trial of self-management support for
primary care patients with COPD in the UK saw an improvement in
their health-related quality of life at 6 months’ follow-up, but this
study only recruited patients with moderate-to-severe disease14.
There was a significant improvement in the patients’ knowledge
of their COPD following the APCOM programme, which was
measured by the COPD-Q32. Increase in patients’ COPD knowledge
was also observed following an interdisciplinary programme to
enhance management of asthma and COPD in primary care33.
There was no significant change in the patients’ perception of
their multi-morbidity, or COPD in the context of multi-morbidity,
following the programme. This might be because the patients
were already aware of the burden imposed by their various
chronic conditions. A British survey that explored factors predict-
ing self-management behaviour34 found that patients’ experience
of multi-morbidity, based on the MULTIPleS35 scale, was not a
critical predictor of self-management; self-management behaviour
was predicted by illness perceptions around the consequences of
individual conditions.
The patients’ inhaler device technique36 significantly improved
following the programme. It is interesting that no prior self-
management interventions for COPD in primary care seemed to
have assessed inhaler technique. This might be due to the lack of
a standard method for assessing inhaler technique for different
types of devices, which imposes a barrier towards its accurate
assessment37.
To the best of our knowledge, the innovative APCOM
programme was a first to provide tailored, self-management
support for primary care patients with COPD in the context of
multi-morbidity. Unlike other self-management programmes for
COPD that used existing interventions and mainly focussed on
physical outcomes30,38, our multi-faceted programme was newly
developed and incorporated a biopsychosocial perspective. This
entailed looking at biomedical as well as psychological aspects39,
and being considerate of patients’ preferences, needs and values,
which are essential for providing self-management support for
chronic disease40. As opposed to other self-management inter-
ventions for COPD in primary care which had a single disease
focus13,14, the APCOM programme considered the implications of
patients’ co-morbidities towards their COPD. Patients were
included irrespective of the severity of their COPD, unlike a British
practice nurse-led, self-management trial of telephone health
coaching, which only included patients with mild symptoms of the
disease41.
All participating general practices and PNs remained in the
study, with 12% of the patients being lost to follow-up, which was
lower than the anticipated dropout rate of 20%42. This shows
feasibility of recruitment and retention of practices for a large-
scale trial. The response rate of 88% at 6 months’ follow-up in our
study was higher than a group self-management initiative for
COPD, which also used PAM 13 as the primary outcome measure
but had a response rate of 47%23. This is further indication of the
effectiveness of personalised self-management support for
empowering patients with COPD. The sample size of our study
was adequate for test−retest reliability of the outcome mea-
sures43. Although a confidence interval of about 80% is deemed
sufficient for analysis of data from pilot studies44, the confidence
interval for analysis of the study’s endpoints was set to 95%.
Table 2. Paired comparison of outcome measures of participants who completed 6 months’ follow-up.
Outcome measure Baseline (SD) Post-programme (SD) Significance* (two-tailed)
PAM 13a (n= 44) 57.69 (±11.01) 64.85 (±16.22) <0.001
CATa (n= 42) 20 (±7) 17.55 (±7.7) 0.012
COPD-Qa (n= 44) 7.27 (±2.12) 9.02 (±2.14) <0.001
MULTIPleSa (n= 43) 25.58 (±14.15) 26.02 (±11.43) 0.822
COPD-MULTIPleSa (n= 42) 12.48 (±6.8) 10.71 (±6.05) 0.084
Proper inhaler device techniqueb (n= 30) 5 (16.67%) 20 (66.67%) 0.001
*Statistical significance was defined as p < 0.05 prior to analysis.
aPaired t test was used to compare the difference in pre- and post-programme outcomes for the five questionnaires with continuous variables.
bPre- and post-programme difference in inhaler device technique, which is a dichotomous variable, was compared using McNemar’s Test.
Table 3. Paired comparison of outcome measures of subset who completed the programme.
Outcome measure Baseline (SD) Post-programme (SD) Significance* (two-tailed)
PAM 13a (n= 35) 59.03 (±10.7) 68.3 (±15.81) <0.001
CATa (n= 34) 19.47 (±6.42) 16.85 (±7.29) 0.024
COPD-Qa (n= 35) 7.6 (±2.14) 9.34 (±1.73) <0.001
MULTIPleSa (n= 35) 25.29 (±13.46) 25.06 (±11.81) 0.907
COPD-MULTIPleSa (n= 34) 12.41 (±6.17) 11.09 (±6.4) 0.237
Proper inhaler device techniqueb (n= 28) 5 (17.86%) 18 (64.28%) 0.002
*Statistical significance was defined as p < 0.05 prior to analysis.
aPaired t test was used to compare the difference in pre- and post-programme outcomes for the five questionnaires with continuous variables.
bPre- and post-programme difference in inhaler device technique, which is a dichotomous variable, was compared using McNemar’s Test.
S Ansari et al.
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A major limitation of our study was the lack of a control group,
which makes it difficult to ascertain whether post-programme
improvement in the outcome measures were solely due to the
programme43. Inclusion of a control group would have required
30 more patient participants (N= 80), with 40 in each group to
estimate test−retest reliability42. This would have required at least
six more PNs and practices, further extending the time for practice
recruitment, which was about 8 months for our study. Given that
the main purpose of this study was to pilot test the effect of a
complex intervention in a real-world clinical setting, it was not
essential to include a control group45.
Given the positive finding from our pilot study, a large-scale
randomised controlled trial based on findings of the APCOM study
is recommended as the next step for research. Such a study needs
to be adequately powered to show a difference in health-related
quality of life and health service utilisation. Interventional studies
are needed for Indigenous patients with COPD and co-morbidities,
in view of greater incidence of the disease in Indigenous
Australians. Initiatives to deliver such tailored, self-management
support for other chronic conditions need to be implemented in
routine general practice, irrespective of who delivers the pro-
gramme. Patients should be educated regarding the correct inhaler
device technique upon initial prescription, and their technique
should be assessed regularly during GP and PN consultations.
In conclusion, the tailored, self-management education pro-
gramme piloted in our study led to improvement in patients’ self-
efficacy in terms of their COPD and overall health behaviour. There
was significant increase in patient activation, COPD knowledge,
COPD-related quality of life and inhaler device technique at
6 months’ follow-up. There was no significant difference in
patients’ perception of their multi-morbidity or COPD-related
multi-morbidity. The study echoes the growing need for
personalised self-management support for COPD in the context
of multi-morbidity at the primary care level. The findings are an
empirical basis for testing the innovative programme as a future
large-scale randomised controlled trial.
METHODS
The APCOM study was a single-group, pre- and post-intervention study
conducted in participating general practices across metropolitan Sydney
from mid-2015 to December 2016. The study comprised development,
piloting and evaluation of an innovative self-management education
programme for COPD in the context of multi-morbidity. The study protocol
and components of the programme have been described in detail
elsewhere46. Ethics approval was obtained from the Human Research
Ethics Committee of UNSW Sydney (HREC14139).
Participant eligibility
General practices were eligible to participate if they maintained an
electronic database of medical records and employed one or more PN.
Patients were included if they: (i) were aged between 40 and 84 years, (ii)
had a record of spirometry diagnosis of COPD in their practice notes and
(iii) had at least one other co-existing chronic condition or co-morbidity.
Patients were excluded if they had cognitive impairment or were unable to
understand sufficient English to complete the study questionnaires and
follow the intervention.
Recruitment
General practices were invited to participate from the Practice Based
Research Network at UNSW Sydney, a group of practices that had previously
participated in research studies conducted by N.Z. and S.D., or expressed an
interest in research participation. An information sheet about the study was
faxed to potential general practices. Practices that did not respond within
2 weeks of the initial invitation were followed up twice by telephone and/or
email. S.A. visited practices that expressed an interest in taking part in the
study and met with the PNs and GPs, briefed them about the study and
obtained their written informed consent.
The PNs were provided with instructions on how to search for eligible
patients in the practice records based on the inclusion criteria. All
potentially eligible patients were sent an invitation letter, including a brief
description of the study. Non-responders were reminded by the PNs via
telephone after 2 weeks. Each PN was asked to recruit five patients for the
study since this number seemed feasible to all.
Intervention
The details of the intervention have been included in the published study
protocol46. In brief, participating PNs attended 1-day workshops facilitated by
the authors and were trained to deliver the self-management education
programme. The PNs were trained to conduct a patient assessment using a
template based on the Health Belief Model47. This assessment identified the
patients’ health priorities and was used by the PNs to facilitate development
of tailored strategies for the patients to support self-management of COPD in
the context of multi-morbidity. One of the authors (S.A.) provided research
support to the PNs during the 6-week programme, which comprised three
face-to-face sessions spaced 2 weeks apart.
During the first PN−patient session, individual patient needs were
assessed and the intervention tailored accordingly. The PNs were asked to
use Motivational Interviewing48 to address barriers faced by the patients in
managing their COPD in the face of co-morbidities. Health information and
referrals to healthcare providers were provided as necessary. Following the
last session, the PNs followed up with the patients via a monthly phone call
for 5 months.
Outcome measures
The primary outcome was the Patient Activation Measure (PAM 13)22.
Secondary outcomes were COPD Assessment Test (CAT)28, COPD Knowledge
Questionnaire (COPD-Q)32, Multimorbidity Illness Perceptions Scale (MULTI-
PleS)35, COPD-specific version of MULTIPleS and inhaler device technique36.
The first hypothesis of the study was addressed by the PAM 13, COPD-Q,
CAT, COPD-MULTIPleS and inhaler device technique, the second hypothesis
was addressed by the COPD-Q, CAT and inhaler device technique, and the
third hypothesis was addressed by the PAM 13 and MULTIPleS.
Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
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